HMGB1 – its role in tumor progression and anticancer therapy
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
HMGB1 is an evolutionarily conserved protein with a wide spectrum of action. Its main receptors are RAGE and TLR found on the surface of immune system cells as well as endothelial cells. Although signaling pathways for both receptor groups are different, ultimately they both activate NFκB transcription factor which, in turn, activates genes encoding adhesion proteins, proinflammatory cytokines and proangiogenic factors. Inside cells, HMGB1 is found mainly in the cell nucleus, where it participates in replication, recombination, transcription and DNA repair processes. Following release into the extracellular space, HMGB1 becomes a proinflammatory cytokine which stimulates formation of new blood microvessels, enhances cell migration, activates the inflammatory condition and affects cell proliferation. HMGB1 protein also takes part in regeneration of damaged tissues and stimulates autophagy. HMGB1 plays a potential role in anticancer therapy. Increased amounts of HMGB1 in cancer cells and elevated levels in the bloodstream are noted among patients afflicted with various cancers. HMGB1 protects cells from apoptosis, as it affects telomere stability. HMGB1 also stimulates a number of proteins involved in proliferation of cancer cells and inhibits signals that control cell growth. Ability to arrest HMGB1 release from cells or to inhibit its activity appears to be a promising therapeutic approach. At present, several inhibitors of HMGB1 are known and can be used in anticancer therapy.
Authors and Affiliations
Ryszard Smolarczyk, Tomasz Cichoń, Magdalena Jarosz, Stanisław Szala
Keywords
Related Articles
- EP ID EP66825
- DOI -
- Views 148
- Downloads 0
The importance of selected spices in cardiovascular diseases
Cardiovascular diseases are the leading cause of death worldwide. Literature data indicate that, due to these diseases, approximately 17.5 million people died in 2012. Types of cardiovascular disease include ischemic hea...
Rola infekcji wirusowych w patogenezie choroby Alzheimera
Choroba Alzheimera (chA) jest najczęściej występującą postacią demencji na świecie, dotyczy przede wszystkim osób starszych. Należy jednak pamiętać, iż zmiany degeneracyjne w mózgu mogą się rozpocząć w każdym wieku. Mimo...
Cutaneous cryptococcosis as a rare manifestation of the immune reconstitution syndrome in an HIV-1-infected patient
Immune reconstitution syndromes (IRS) in HIV-1-infected patients are associated with an exaggerated infl ammatory response against an opportunistic infection during highly active antiretroviral therapy (HAART). The most...
Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) patients are at high risk for infections. The pathogenesis of infection in patients with this leukemia is complex and multifactorial. Patients with CLL have a number of immune system de...
Udział czynników genetycznych (polimorfizm PON1) i środowiskowych, a zwłaszcza aktywności fizycznej, w procesie antyoksydacyjnego działania paraoksynazy
Paraoksonaza 1 (PON1) należy do trójgenowej rodziny enzymów (PON1, PON2 i PON3). W osoczu człowieka dominuje aktywność PON1. Enzym ten wydzielany jest przez hepatocyty wątroby do krwi, gdzie wiąże się z lipoproteiną o du...